Kanatzhan Kemelbekov

Kanatzhan Kemelbekov

Auto-generated profile, based on publicly available information

Kanatzhan Kemelbekov

Scientific—Clinical Center of Cardiac Surgery and Transplantation, Taraz, Kazakhstan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2021 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
KKKanatzhan Kemelbekov
Kanatzhan Kemelbekov
YMYuldash Musaev
Yuldash Musaev
GBGulmira Bektenova
Gulmira Bektenova
GDGulmira Datkayeva
Gulmira Datkayeva
STSaule Tuktibayeva
Saule Tuktibayeva
NTNurgeldi Tasbulatov
Nurgeldi Tasbulatov
The open ductus arteriosus (ODA) is the vessel through which the pathological communication between the aorta and the pulmonary artery persists after birth. Clinical manifestations depend on the size of the duct and the stage of hemodynamic disorders. The course of the defect varies from asymptomatic to extremely severe. With large duct sizes, the latter manifests itself from the first week of life with signs of heart failure. The current research is devoted to the choice of the optimal method of medical and surgical treatment in premature newborns with an unaffected ductus arteriosus. Drug therapy for pulmonary hypertension is recommended only for those patients who have irreversible pulmonary hypertension. Surgical closure of the ODA is recommended for overloads of the left heart or signs of pulmonary hypertension in the presence of blood discharge from left to right and after previously suffered endocarditis. The article analyzes current information about the treatment of premature infants with ODA.